Nutritional Aesthetics Alliance
MARCH 10, 2024
Acne. It’s one of the most common reasons people seek help from skin professionals across modalities, whether it’s from a dermatologist, (a)esthetician, nutritionist, health coach, herbalist, acupuncturist, what have you. Like most skin conditions, acne doesn’t have just one cause or one treatment that will work–it can be complicated.
Dermatology Times
MARCH 10, 2024
Lloyd Miller, MD, PhD, delves into the new data demonstrating high rates of skin clearance over 52 weeks in adults with moderate to severe plaque psoriasis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Skin Games
MARCH 10, 2024
Looking to refine your skills and expand your knowledge in the skincare industry? The Skin Games 2024 Live Event Part II offers a wide range of advanced education courses designed to elevate your practice and boost your success.
Dermatology Times
MARCH 10, 2024
Joseph Zabinski, PhD, MEM, of OM1, shares insights at AAD into how artificial intelligence can mature and be a positive tool for disease detection.
Lydia Sarfati
MARCH 10, 2024
Join Lydia Sarfati as we demonstrate the latest addition to our exclusive treatment lineup – the Repêchage T-Zone Classic Facial, a CIDESCO International endorsed procedure. This innovative facial is specially crafted to target and transform the most problematic areas of your skin, leaving you with a flawless, radiant complexion. This webinar will include information on: – Ingredients and treatments to truly address combination skin to help eliminate oiliness in the T-Zone while maintainin
Dermatology Times
MARCH 10, 2024
Shawn Kwatra, MD, presented late-breaking data at AAD 2024 on the largest prurigo nodularis and nemolizumab clinical trial, OLYMPIA.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
MARCH 10, 2024
Maria Aleshin, MD, FAAD, presented surgical procedures for HS that can be performed in the office.
The Dermatology Digest
MARCH 10, 2024
Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, discusses findings from the phase 3 maximal use arm of the ASCEND Trial that looked at topical isotretinoin 0.05% (TMB-001) in congenital ichthyosis. The upshot? Topical isotretinoin, even when applied to 90% of a patient’s body surface area, showed minimal systemic absorption.
Dermatology Times
MARCH 10, 2024
Eichenfield discusses the late-breaking data on roflumilast cream 0.05% in the pediatric patient population and its implications.
The Dermatology Digest
MARCH 10, 2024
Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA, reviews currently available and emerging treatments for chronic spontaneous urticaria (CSU), including dupilumab (Dupixent, Sanofi, and Regeneron Pharmaceuticals), remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase (BTK) inhibitor, other BTK inhibitors, interleukin 5 (IL-5) inhibitors and C-kit blockers.
Dermatology Times
MARCH 10, 2024
The congenital ichthyosis session the 2024 AAD Annual Meeting covered real-world patient cases and treatments on the horizon.
The Dermatology Digest
MARCH 10, 2024
This content is password protected. To view it please enter your password below: Password: The post Protected: The Lowdown on Molluscum appeared first on The Dermatology Digest.
Dermatology Times
MARCH 10, 2024
Burnett recently spoke with Dermatology Times to discuss the background, methods, and findings of the late-breaking INTEGUMENT-PED data, as well as its potential real-world and clinical implications.
Aesthetics Advisor
MARCH 10, 2024
In this interview below, Christy Sutton, D.C., reviews the dangers of excessive iron. While most doctors look for iron deficiency, few ever pay attention to elevated iron. Sutton is the author of two books, “ Genetic Testing: Defining Your Path to a Personalized Health Plan: An Integrative Approach to Optimize Health ,” and “ The Iron Curse, Is Your Doctor Letting High Iron Destroy Your Health?
Dermatology Times
MARCH 10, 2024
Discover the science behind cosmeceutical advancements and the importance of staying informed for enhanced patient care with Zoe Diana Draelos, MD.
Aesthetics Advisor
MARCH 10, 2024
In the following sections, we’ll outline gene-based approaches that may help you deal with eczema. Read on to find out what you can do to manage this condition. The below strategies are not meant to replace your standard medical treatment. Make sure to consult with your doctor before making any significant changes to your day-to-day routine. This post has more than 300 evidence based references.
Dermatology Times
MARCH 10, 2024
Melinda Gooderham, MSc, MD, FRCPC, provided insights into the significance of the DELTA 3 extension data presented at AAD 2024.
Aesthetics Advisor
MARCH 10, 2024
Randomized, double-blind, controlled trials suggest that excluding certain foods, such as eggs and chicken, can significantly improve atopic dermatitis. Infants of mothers randomized to cut out eggs, milk, and fish were significantly less likely to have eczema even years later. Eczema, also known as atopic dermatitis, is a chronic inflammatory skin disease.
Dermatology Times
MARCH 10, 2024
In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.
The Dermatology Digest
MARCH 10, 2024
From distraction techniques to pharmacologic measures, Peter A. Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, shares pearls on keeping pediatric patients comfortable during common dermatologic procedures. More Conference Coverage CSU Is for You Adam Friedman, MD Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and
Dermatology Times
MARCH 10, 2024
Catch up on coverage from the third day of the 2024 American Academy of Dermatology Annual Meeting.
The Dermatology Digest
MARCH 10, 2024
More than two-thirds of people with atopic dermatitis (AD) and darker skin tones treated with lebrikizumab showed improvements in skin clearance and itch relief, according to late-breaking results from a Phase 3 study are being presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego. Lebrikizumab (Ebglyss, Almirall), an interleukin-13 (IL-13) inhibitor, just received European Commission approval this year, and it is making its way down the pike in the US too.
Dermatology Times
MARCH 10, 2024
In an exclusive interview with Gary Dudzik, he shared top 5 considerations dermatology clinicians should have when choosing financial services for their practices and overall financial goals.
Aesthetics Advisor
MARCH 10, 2024
Americans are increasingly taking control of their health via the use of health monitoring technologies, with notable benefits as a result. A Cleveland Clinic survey revealed that 50% of Americans use at least one type of technology to track their health, with most experiencing significant related physical and mental improvements. 1 If you’re considering investing in a fitness tracker or other form of wearable, health-tracking technology, however, there are some caveats to consider, including ef
Dermatology Times
MARCH 10, 2024
The phase 3 studies, BE HEARD I and BE HEARD II, showed significant improvements in skin pain over the 48-week period.
Aesthetics Advisor
MARCH 10, 2024
Vitamin B complex refers to a group of 8 water-soluble B vitamins and the supplement made from a compound of them. This vitamins work synergistically together and are vital for the human body. Vitamin B complex can be quickly absorbed by the intestine and excreted through renal metabolism. It then acts as a coenzyme in many catabolic and anabolic enzymatic reactions, which play an integral role in cell function.
Expert insights. Personalized for you.
195 
Let's personalize your content